FEATURED EDITORIAL
The gold standard practice of conducting animal studies for evaluating toxicity, pharmacodynamics, and immunogenicity is being challenged by innovative alternatives – New Approach Methods (NAMs).
- TYK2 Inhibition Emerges As A Next-Gen Strategy To Treat PsA
- Multi-Indication Strategies Reshape Immunology's R&D Strategy
- Immunology's Next Frontier: High-Risk, High-Reward Innovations From EULAR 2025
- New Regulatory Considerations For Animal Testing And The Consequences For Drug Product Formulation Development
- From Undruggable To Druggable: The Science Reshaping Small Molecule Discovery
- Five Takeaways from BIO 2025 and Why You Should Stay Tuned
- From Matrix To Medicine: New Frontiers In Treating Pulmonary Fibrosis And PH
FEATURED APPLICATION CONTENT
-
Explore the challenges associated with cell line development in the production of biologics, and solutions that can help biotech developers evade the pitfalls of misinformed decision-making.
-
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
Discover a company that tripled productivity and cut costs by optimizing its seed train process to achieve major gains without infrastructure expansion.
-
Discover how a top CDMO leveraged dynamic perfusion technology to boost biomanufacturing throughput, cut capital costs, and enable flexible, multi-modality production.
-
Explore cost-saving innovations in purification using a system that achieves consistent product quality and yield while significantly reducing resin use and enhancing large-scale efficiency.
-
Discover how a leading biopharma company boosted flexibility and quadrupled productivity by implementing a concentrated fed-batch process in a single-use facility.
-
Decarbonizing healthcare and pharmaceuticals is vital to meet climate goals and safeguard public health. Learn why these energy-intensive sectors must act swiftly to reduce emissions and navigate complex global supply chains.
-
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
Raman spectroscopy has revolutionized manufacturing through real-time monitoring. Explore a system that enables a seamless calibration model transfer from small- to large-scale bioreactors to enhance scalability and efficiency.
-
Adeno-associated virus is a key gene therapy vector. Explore how digital PCR offers precise, standard-free quantification with improved consistency and inhibitor tolerance over traditional qPCR methods.
-
Digital PCR offers precise, inhibitor-resistant DNA quantification and genome integrity assessment. Discover how this method enhances accuracy and reproducibility, especially in AAV analysis, using multiplexed targets and Poisson-based calculations.
-
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
FEATURED NEWS HEADLINES
- New Partnership With Parkinson's Research Foundation To Accelerate Parkinson's Drug Discovery
- Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement To Support ONP-002 Clinical Development
- C-Path's Translational Therapeutics Accelerator Announces $200,000 Grant For Drug Development Project In Inflammatory Bowel Disease
- SandboxAQ And iOncologi Partner To Accelerate Brain Cancer Treatment With AI-Driven Drug Discovery For Glioblastoma
- Blocking A Little-Known Protein May Offer New Hope For Devastating Lung Disease
- Corcept Submits New Drug Application For Relacorilant As A Treatment For Patients With Platinum-Resistant Ovarian Cancer
- Integrated Biosciences Unveils First-Of-Its-Kind Optogenetic Screening Platform For Drug Discovery
- Divamics' AI And Molecular Dynamics Platform Powers Breakthroughs In Metabolic Disease Drug Discovery For Partners
- TandemAI And Perpetual Medicines Announce Strategic Merger To Expand Physics And AI-Based Drug Discovery Capabilities
- U.S. FDA Accepts New Drug Application For Merck's Doravirine/Islatravir, An Investigational, Once-Daily, Oral, Two-Drug Regimen For Treatment Of Adults With Virologically Suppressed HIV-1 Infection
ARCHIVED NEWSLETTER
- 07.18.25 -- Innovation driving access in advanced therapies
- 07.15.25 -- Radiopharmaceuticals: Navigating FDA Guidance And CMC Considerations
- 07.10.25 -- Take a look at our useful PUPSIT overview and implementation resources.
- 07.08.25 -- Designing Our Way Toward Circular RNA Medicines With AI
- 07.01.25 -- Will Genome Modifications Define Next-Gen AAV Vectors?